Search

Political apologies have been theorized to play an important role in healing and reconciliation processes in post‐conflict settings. Whether they actually fulfil this function, however, remains unclear as the voices and perspectives of victim communities have largely been underrepresented in research. To address this, we examined the role of apologies that were offered for the El Mozote massacre (El Salvador), the Jeju 4.3 massacres (Republic of Korea) and Bloody Sunday (United Kingdom), according to members of these communities and the broader public. Although we anticipated that victim community members should find the apology more valuable and meaningful and should, therefore, be more positive about its role in healing and reconciliation processes, we found that this varies across countries. This variation could be explained by people's trust in the country's institutions. Across the samples, we found that the apology was seen as a relatively important gesture. For the apology to be perceived as impactful, however, it had to be seen as a meaningful (i.e. sincere) gesture. Our findings suggest that apologies have a role to play in the aftermath of human rights violations, but that it is essential to take the broader context into account. [ABSTRACT FROM AUTHOR]

The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening global health. However, an understanding of the interaction of SARS-CoV-2 with human cells, including the physical docking property influenced by the host's genetic diversity, is still lacking. Here, based on germline variants in the UK Biobank covering 502,543 individuals, we revealed the molecular interactions between human angiotensin-converting enzyme 2 (hACE2), which is the representative receptor for SARS-CoV-2 entry, and COVID-19 infection. We identified six nonsense and missense variants of hACE2 from 2585 subjects in the UK Biobank covering 500000 individuals. Using our molecular dynamics simulations, three hACE2 variants from 2585 individuals we selected showed higher levels of binding free energy for docking in the range of 1.44–3.69 kcal/mol. Although there are diverse contributors to SARS-CoV-2 infections, including the mobility of individuals, we analyzed the diagnosis records of individuals with these three variants of hACE2. Our molecular dynamics simulations combined with population-based genomic data provided an atomistic understanding of the interaction between hACE2 and the spike protein of SARS-CoV-2. Author summary: To understand diverse infection rate of novel coronavirus disease (COVID-19) depending on individuals, it is of great importance to elucidate the interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human cell. In this study, we conducted computational mutagenesis study to understand the relationship between variants of human angiotensin converting enzyme 2 (hACE2), which is the major human cell receptor for SARS-CoV-2 entry, and COVID-19 infection. Massive data analysis of UK biobank database allowed us to find substantial evidences of altered COVID-19 infection by hACE variants. In addition, molecular dynamics simulation provided us atomistic understanding of interaction between hACE2 and spike protein of SARS-CoV-2. [ABSTRACT FROM AUTHOR]

Background: Previous research has shown that the use of renin-angiotensin system (RAS) blockers is linked to a lower prevalence of posttraumatic stress disorder (PTSD), but longitudinal studies are scarce. We aimed to estimate the association between the use of RAS blockers and the risk of PTSD among individuals taking antihypertensive medications., Methods: This longitudinal study included participants aged 40-69 from the UK Biobank. Exposure data were obtained from the initial assessment (2006-10), while outcome data were obtained from the online mental health questionnaire administered 6-11 years later (2016-17). We included participants who were under antihypertensive treatment and did not have a prior diagnosis of PTSD before the initial assessment. Use of RAS blockers was defined as self-reported regular use, at the initial assessment, of angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB). Among participants who experienced adverse life experiences, cases of probable PTSD were defined with the six-item PTSD Checklist-Civilian version score ≥ 14. Logistic regression with inverse probability of treatment weighting was used to estimate the odds ratios (ORs) and 95% confidence interval (CI) for the association between RAS blocker use and the risk of probable PTSD., Results: Of the 15,954 participants (mean age = 59.9 years; 42.6% women) under antihypertensive treatment with no prior history of PTSD at the initial assessment, 64.5% were taking RAS blockers. After a mean follow-up of 7.5 years, 1,249 (7.8%) were newly identified with probable PTSD. RAS blocker users had a lower risk of probable PTSD than RAS blocker non-users (OR = 0.84 [95% CI: 0.75-0.94]), whereas the use of other antihypertensive medications showed no such association (users vs. non-users; calcium channel blockers, OR = 0.99 [95% CI: 0.88-1.11]; beta-blockers, 1.20 [1.08-1.34]; and thiazide-related diuretics, 1.15 [1.03-1.29]). The association between probable PTSD risk and the use of ACEi vs. ARB showed no significant difference (p = 0.96)., Conclusions: Among individuals under antihypertensive treatment, the use of RAS blockers was associated with a decreased risk of probable PTSD. This added benefit of RAS blockers should be considered in the selection of antihypertensive medications., (© 2024. The Author(s).)